Yamazaki K, Goto M, Koinuma S, Hishinuma K, Yamazaki S, Murashima A et al: Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester. Congenit Anom (Kyoto). 2026;66(1):e70056
Suzuki T, Goto M, Anzai T, Yamane R, Watanabe O, Takahashi K et al: Clarithromycin Use in the First Trimester Is Not Associated With Fetal Abnormalities. Congenit Anom (Kyoto). 2026;66(1):e70041
Fujioka I, Goto M, Anzai T, Takahashi K, Koinuma S, Murashima A: Pregnancy and neonatal outcomes following statin exposure in early pregnancy: a nationwide consultation-based cohort study in Japan. BMC Pregnancy Childbirth. 2026;26(1):449
Ogawa Y, Kamiya T, Tagawa N, Aoki S, Kobayashi M, Sato Y, Tanaka S, Wakabayashi H, Mizuno K: Measurement of Atrial Natriuretic Peptide (ANP) Concentrations in Human Breast Milk and Maternal Plasma during Carperitide Therapy (Two Case Reports). J Hum Lact. (in press)
Takai C, Fujioka I, Goto M: PRAISE-H study exploring real-world challenges faced by reproductive-age patients with rheumatoid arthritis in Japan. Front Med (Lausanne). 2026;13:1773628
Goto M, Fujioka I, Ogawa Y, Koinuma S, Yamaguchi K: Limitations of FAERS-based analyses of paternal drug exposure: The critical need for maternal data integration. Andrology. 2026;14(2):412-419
Goto M, Fujioka I, Koinuma S, et al: Pregnancy and Neonatal Outcomes After First-Trimester Exposure to Bucillamine: A Case Series from a Japanese Teratology Information Service. PMDRS (医薬品医療機器レギュラトリーサイエンス). 2026;57(2):165-170
Goto M, Kohno C, Takai C, Miyagawa E, Yanai R, Yajima N et al: Systematic review of the treatment of rheumatoid arthritis patients of reproductive age: Informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis – secondary publication. Mod Rheumatol. 2025;35(2):roaf087
Matsuda S, Yakuwa N, Goto M, Akazawa M, Takahashi K, Anzai T et al: Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy Pharmacovigilance. Drug Saf. 2025;48(9):1035-1046
Koinuma S, Goto M, Saito J, Murashima A, Takeshita T: Transfer of amenamevir into breast milk in breastfeeding patients with recurrent herpes simplex: study protocol for a single-arm, open-label study. Front Pediatr. 2025;13:1551335
Ohtsu H, Fujioka I, Goto M, Takai C, Yonemoto N, Sase K et al: Five-Year Delivery Rate and Time to Delivery Among Women With and Without Rheumatoid Arthritis: A Real-World Analysis Using a Nationwide Claims Database in Japan. Int J Rheum Dis. 2025;28(6):e70296
Hirasawa Y, Tagashira H, Ueno A, Tasaka Y, Goto M, Murashima A, Yamamoto H: Maternal Mosapride Citrate Hydrate Exposure During the First Trimester: Assessing Risks for Congenital Anomalies. Dig Dis Sci. 2025; [Online ahead of print] doi: 10.1007/s10620-025-09197-3
Hongoh M, Fujioka I, Goto M, Yamane R, Tamaki H, Murashima A, Yano T: Evaluation of the Safety of Lansoprazole Exposure During Early Pregnancy: A Prospective Cohort Study Using Two-Center Counseling Data in Japan. Yakugaku Zasshi. 2025;145(12):967-973
Goto M, Saito S, Scheuerle A, Yasuda S, Houston N, Kumke T, Lauwerys B et al: Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol. Int J Rheum Dis. 2025;28(1):e70048
Koinuma S, Sasaki A, Murayama K, Sueoka K, Murashima A, Kasahara M: Successful pregnancy in a patient with OTCD using advanced technologies and liver transplant. Pediatr Int. 2025;67(1):e70006
Honma M, Suzuki N, Goto M, Obara T, Saito Y, Nakajima K et al: A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan. Congenit Anom (Kyoto). 2025;65(1):e12588
Yakuwa N, Miura Y, Koinuma S, Fujioka I, Goto M, Murashima A, Yamaguchi K: Unintended Pregnancies Associated with Unapproved Isotretinoin Use in Japan: A 20-year Case Series from the Japan Drug Information Institute in Pregnancy. PMDRS (医薬品医療機器レギュラトリーサイエンス). 2025;56(6):504-509
Usuda M, Jwa SC, Goto M, Kobayashi M, Nagano H, Yakuwa N et al: Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy. Congenit Anom (Kyoto). 2024;64(3):91-98
Miki Y, Koga Y, Taogoshi T, Itamura R, Yokooji T, Hishinuma K et al: Assessment of the Safety of Exposure to Cefcapene Pivoxil during the First Trimester of Pregnancy: A Prospective Cohort Study in Japan. Biol Pharm Bull. 2024;47(7):1301-1306
Goto M, Anzai T, Yamane R, Yakuwa N, Takahashi K, Murashima A: Pregnancy outcomes after first-trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions. Congenit Anom (Kyoto). 2024;64(5):199-206
Nishimura A, Furugen A, Kobayashi M, Takekuma Y, Yakuwa N, Goto M et al: Effects of famotidine use during pregnancy: an observational cohort study. J Pharm Health Care Sci. 2024;10(1):70
Saito J, Yakuwa N, Hosokawa Y, Hamada H, Suzuki T, Sago H et al: Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi-institutional study. Br J Clin Pharmacol. 2024;90(1):146-157
Yakuwa N, Murashima A, Miyazaki S: Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in Pregnancy. Congenit Anom (Kyoto). 2024;64(1):6-16
拠点病院関係者ページ